83 related articles for article (PubMed ID: 15876485)
1. Increased thromboxane B(2) levels are associated with lipid peroxidation and Bcl-2 expression in human lung carcinoma.
Chen GG; Lee TW; Yip JH; Xu H; Lee IK; Mok TS; Warner TD; Yim AP
Cancer Lett; 2006 Mar; 234(2):193-8. PubMed ID: 15876485
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
3. Alteration of APE1/ref-1 expression in non-small cell lung cancer: the implications of impaired extracellular superoxide dismutase and catalase antioxidant systems.
Yoo DG; Song YJ; Cho EJ; Lee SK; Park JB; Yu JH; Lim SP; Kim JM; Jeon BH
Lung Cancer; 2008 May; 60(2):277-84. PubMed ID: 18061304
[TBL] [Abstract][Full Text] [Related]
4. Serum vascular endothelial growth factor (VEGF) and bcl-2 levels in advanced stage non-small cell lung cancer.
Tas F; Duranyildiz D; Oguz H; Camlica H; Yasasever V; Topuz E
Cancer Invest; 2006 Oct; 24(6):576-80. PubMed ID: 16982461
[TBL] [Abstract][Full Text] [Related]
5. Comparison of hydrogen peroxide generation and the content of lipid peroxidation products in lung cancer tissue and pulmonary parenchyma.
Zieba M; Suwalski M; Kwiatkowska S; Piasecka G; Grzelewska-Rzymowska I; Stolarek R; Nowak D
Respir Med; 2000 Aug; 94(8):800-5. PubMed ID: 10955757
[TBL] [Abstract][Full Text] [Related]
6. Bax, bcl-2 and c-kit expression in non-small-cell lung cancer and their effects on prognosis.
Yaren A; Oztop I; Kargi A; Ulukus C; Onen A; Sanli A; Binicier O; Yilmaz U; Alakavuklar M
Int J Clin Pract; 2006 Jun; 60(6):675-82. PubMed ID: 16805752
[TBL] [Abstract][Full Text] [Related]
7. Comparison of changes in erythrocyte and platelet fatty acid composition and protein oxidation in advanced non-small cell lung cancer.
de Castro J; Hernández-Hernández A; Rodríguez MC; Llanillo M; Sánchez-Yagüe J
Cancer Invest; 2006; 24(4):339-45. PubMed ID: 16777684
[TBL] [Abstract][Full Text] [Related]
8. Alterations in lipid peroxidation and antioxidant status in different types of intracranial tumors within their relative peritumoral tissues.
Zengin E; Atukeren P; Kokoglu E; Gumustas MK; Zengin U
Clin Neurol Neurosurg; 2009 May; 111(4):345-51. PubMed ID: 19117666
[TBL] [Abstract][Full Text] [Related]
9. Apoptotic markers p53, Bcl-2 and Bax in primary lung cancer.
Porebska I; Wyrodek E; Kosacka M; Adamiak J; Jankowska R; Harłozińska-Szmyrka A
In Vivo; 2006; 20(5):599-604. PubMed ID: 17091766
[TBL] [Abstract][Full Text] [Related]
10. Distribution of Bcl-2 gene expression and its prognostic value in non-small cell lung cancer.
Yilmaz A; Savaş I; Dizbay Sak S; Güngör A; Kaya A; Serinsöz E; Savaş B
Tuberk Toraks; 2005; 53(4):323-9. PubMed ID: 16456730
[TBL] [Abstract][Full Text] [Related]
11. Expression of pigment epithelial derived factor is reduced in non-small cell lung cancer and is linked to clinical outcome.
Zhang L; Chen J; Ke Y; Mansel RE; Jiang WG
Int J Mol Med; 2006 May; 17(5):937-44. PubMed ID: 16596284
[TBL] [Abstract][Full Text] [Related]
12. [The role of Smad4 and MAPK proteins in signal transduction pathway in non-small cell lung cancer].
Tong XD; Liu HX; Zhao HR; Xu SG; Li Y; Han LB; Zhang L
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):741-5. PubMed ID: 17366784
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of STAT5 and Bcl-xL, and high expression of Neu and STAT3 in non-small-cell lung carcinoma.
Sánchez-Ceja SG; Reyes-Maldonado E; Vázquez-Manríquez ME; López-Luna JJ; Belmont A; Gutiérrez-Castellanos S
Lung Cancer; 2006 Nov; 54(2):163-8. PubMed ID: 16959370
[TBL] [Abstract][Full Text] [Related]
14. [Nuclear factor-kappaB activity and its correlation with cell proliferation in non-small cell lung cancer tissues].
Zhang J; Xu YJ; Zhang ZX; DU CL; Qiao LF; Ni W; Chen SX
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Oct; 30(10):771-5. PubMed ID: 18218209
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus type 16/18 up-regulates the expression of interleukin-6 and antiapoptotic Mcl-1 in non-small cell lung cancer.
Cheng YW; Lee H; Shiau MY; Wu TC; Huang TT; Chang YH
Clin Cancer Res; 2008 Aug; 14(15):4705-12. PubMed ID: 18676738
[TBL] [Abstract][Full Text] [Related]
16. [Expression of SKP2 protein in lung carcinoma and its implication for prognosis].
Zhao J; Yang CL; Zhao SY
Zhonghua Zhong Liu Za Zhi; 2007 Apr; 29(4):289-92. PubMed ID: 17760257
[TBL] [Abstract][Full Text] [Related]
17. [Correlation of P27 expression and localization to phosphorylated AKT in non-small cell lung cancer].
Miao LJ; Wang J; Li SS; Wu YM; Wu YJ; Wang XC
Ai Zheng; 2006 Oct; 25(10):1216-20. PubMed ID: 17059763
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of insulin receptor substrate-I down-regulation in non-small cell lung cancer.
Han CH; Cho JY; Moon JT; Kim HJ; Kim SK; Shin DH; Chang J; Ahn CM; Kim SK; Chang YS
Oncol Rep; 2006 Dec; 16(6):1205-10. PubMed ID: 17089038
[TBL] [Abstract][Full Text] [Related]
19. The expression of RNA-binding protein HuR in non-small cell lung cancer correlates with vascular endothelial growth factor-C expression and lymph node metastasis.
Wang J; Zhao W; Guo Y; Zhang B; Xie Q; Xiang D; Gao J; Wang B; Chen Z
Oncology; 2009; 76(6):420-9. PubMed ID: 19420963
[TBL] [Abstract][Full Text] [Related]
20. Elevated activities of MMP-2 in the non-tumorous lung tissues of curatively resected stage I NSCLC patients are associated with tumor recurrence and a poor survival.
Kim SH; Choi HY; Lee J; Son DS; Lee HS; Song IS; Lim YS; Hong YS; Kim J; Choi YS
J Surg Oncol; 2007 Mar; 95(4):337-46. PubMed ID: 17326127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
